A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2008, Vol 1, Issue 1

Abstract

Background: Insulin glargine provides effective glycemic control when administered at bedtime in adults. Objective: This study aims to investigate whether insulin glargine is equally effective if administered in the morning or at bedtime in combination with preprandial anologue insulin. Methods: Twenty-eight patients that have been treated with an intensified insulin regimen for at least one year were randomized to insulin glargine injection at breakfast (06:00-09:00) (12 patients) or bedtime (21:00-24:00) (16 patients), plus meal-time anologue insulin in the two groups. Glucose data from each day were analyzed at four different times: between 9:00 and 21:00 (t1), between 21:00 and 24:00 (t2), between 24:00 and 04:00 (t3),04:00 and 09:00 (t4) by the Minimed continuous glucose monitoring system. Results: Baseline characteristics were similar in the two groups. The sensor values were lower before breakfast in the bedtime group (180.5 ± 49.0 vs 223.8 ± 47.3 mg/dl, p=0.03). There were 13.7 events.patient -1.day-1 in the bedtime group and 6.9 events.patient -1.day-1 in the breakfast group in which glucose levels fell below 60 mg/dl (p=0.3). There were 121.6 events.patient -1.day-1 in the bedtime group and 162.4 events.patient -1.day-1 in the breakfast group in which glucose levels exceeded 180 mg/dl (p=0.05). Nighttime hypoglycemia only reached to a statistical significance between the two groups between 24:00 and 04:00. There were no significant correlations between the duration of nocturnal hypoglycemia, age, duration of diabetes, gender and HbA1c levels. Conclusion: Breakfast group is hyperglycemic during the day and hyperglycemia starts in the morning at 04:00. There is no significant difference in the frequency or duration of hypo/hyper glycemia during the day and night irrespective of the timing of glargine injection except pre-breakfast levels are significantly better in the bedtime group and hypoglycemia occurs between midnight and 04:00 in the bedtime group. DOI: 10.4008/jcrpe.v1i1.10

Authors and Affiliations

Damla Şimşek, Başak Yıldız, Gülgün Asar, Şükran Darcan

Keywords

Related Articles

A Novel Mutation Causing Pseudohypoparathyroidism 1A with Congenital Hypothyroidism and Osteoma Cutis

Various inactivating mutations in guanine nucleotide-binding protein, alpha-stimulating activity polypeptide1 (GNAS1) gene have been described with poor phenotype correlation. Pseudohypoparathyroidism type 1a (PHP1a) res...

Therapeutic Approach to Obesity in Children and Adolescents

The increasing incidence of obesity and of metabolic syndrome among children and adolescents has become a problem in Turkey as in the rest of the world. Given its detrimental effects on public health and the costs of its...

Prevalence of Cryptorchidism Among Bulgarian Boys

Background: Cryptorchidism is the most common congenital defect of the male urogenital system. It may be an important cause for male infertility. The data about its prevalence in South-eastern European countries and espe...

Audit of Microalbumin Excretion in Children with Type I Diabetes

Objective: To investigate prevalence, persistence and clinical correlates of increased microalbumin excretion in random urine samples collected in a paediatric diabetes clinic. Method: Random urine samples were collect...

The relationship between serum ghrelin levels and hair zinc concentrations in children

Background: Zinc (Zn) plays a central role in the activation of numerous enzyme systems that synthesize and degrade bioactive peptides. Some of these bioactive peptides, also called neuropeptides, are involved in the reg...

Download PDF file
  • EP ID EP102336
  • DOI -
  • Views 96
  • Downloads 0

How To Cite

Damla Şimşek, Başak Yıldız, Gülgün Asar, Şükran Darcan (2008). A Randomized Clinical Trial Comparing Breakfast and Bedtime Administration of Insulin Glargine in Children and Adolescents with Type 1 Diabetes. Journal of Clinical Research in Pediatric Endocrinology, 1(1), 15-20. https://europub.co.uk/articles/-A-102336